Expression vector of human integrin alpha5.
Clone info. | Expression vector of human integrin alpha5. |
---|---|
Vector backbone | pcDNA3.1(+)cs (Plasmid) |
Selectable markers | Amp^r (E. coli), Neo^r (mammalian cell) |
Gene/insert name | Human integrin alpha5 cDNA |
Depositor|Developer | Hamada, Hirofumi | |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment ![]() ![]() ![]() MTA, for use for not-for-profit academic purpose [Word ![]() ![]() Please visit Information of Request for Distribution.[link] |
---|---|
Terms and conditions for distribution | The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for profit institution for a not-for-profit research. RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested (Ishii, K. et al., J. Gene Med. 10 (6): 597-609, 2008; Tanaka, T. et al., Clin. Cancer Res. 12 (12): 3803-3813, 2006). In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. |
必要書類 | 提供依頼書 ![]() ![]() 提供同意書 (MTA, 非営利学術目的用)[Word ![]() ![]() 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
---|---|
MTAに書く使用条件 | 非営利機関の非営利学術研究へ提供する。利用者が本件リソースを利用した研究成果に基づき特許申請、商業活動等を行う場合、利用者は事前に寄託者に連絡する。利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する(Ishii, K. et al., J. Gene Med. 10 (6): 597-609, 2008; Tanaka, T. et al., Clin. Cancer Res. 12 (12): 3803-3813, 2006)。利用者は、研究成果の公表にあたって謝辞の表明を必要とする。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB07658 | pcDNA3.1(+)cs-h Integrin alpha5 | DNA solution |
JPY 9,460 (not-for-profit academic purpose) plus cost of shipping containers, dry ice (if required) and shipping charge |
Materials & Methods section:
The pcDNA3.1(+)cs-h Integrin alpha5 was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB07658). |
Reference section:
Ishii, K., Nakamura, K., Kawaguchi, S., Li, R., Hirai, S., Sakuragi, N., Wada, T., Kato, K., Yamashita, T., Hamada, H., Selective gene transfer into neurons via Na,K-ATPase beta1. Targeting gene transfer with monoclonal antibody and adenovirus vector. J. Gene Med., 10, 597-609 (2008). PMID 18383483. |
Tanaka, T., Huang, J., Hirai, S., Kuroki, M., Kuroki, M., Watanabe, N., Tomihara, K., Kato, K., Hamada, H., arcinoembryonic antigen-targeted selective gene therapy for gastric cancer through FZ33 fiber-modified adenovirus vectors. Clin. Cancer Res., 12, 3803-3813 (2006). PMID 16778108. |
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB07658_A9Kbp1-1.pdf ![]() |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: CMV_Forward (Pr0016) Region: CMV pro,attB1,I-CeuI,insert5' Sequence file: RDB07658_A9Kba.seq ![]() |
---|
>07658_07658_A9Kb_2_CMV-Forward_B11_05_ABI24.ab1 1 NNNNNNNNNN NNNNNTGNNG CNNNGGGCGG TANGCGTGTA CGGTGGGAGG TCTATATAAG 61 CAGAGCTCTC TGGCTAACTA GAGAACCCAC TGCTTACTGG CTTATCGAAA TTAATACGAC 121 TCACTATAGG GAGACCCAAG CTGGCTAGCG TTTAAACTTA AGCTTGGTAC CGAGCTCGGA 181 TCCACAAGTT TGTACAAAAA AGCAGGCTTG TAAAACGACG GCCAGTAACT ATAACGGTCC 241 TAAGGTAGCG AGGCCTGGGT GGCGAATTCG GCACGAGGGT TTAGGAAGCG GCTCCGGGTC 301 GGTGGCCCCA GGACAGGGAA GAGCGGGCGC TATGGGGAGC CGGACGCCAG AGTCCCCTCT 361 CCACGCCGTG CAGCTGCGCT GGGGCCCCCG GCGCCGACCC CCGCTGCTGC CGCTGCTGTT 421 GCTGCTGCTG CCGCCGCCAC CCAGGGTCGG GGGCTTCAAC TTAGACGCGG AGGCCCCAGC 481 AGTACTCTCG GGGCCCCCGG GCTCCTTCTT CGGATTCTCA GTGGAGTTTT ACCGGCCGGG 541 AACAGACGGG GTCAGTGTGC TGGTGGGAGC ACCCAAGGCT AATACCAGCC AGCCAGGAGT 601 GCTGCAGGGT GGTGCTGTCT ACCTCTGTCC TTGGGGTGCC AGCCCCACAC AGTGCACCCC 661 CATTGAATTT GACAGCAAAG GCTCTCGGCT CCTGGAGTCC TCACTGTCCA GCTCAGAGGG 721 ANAGGAGCCT GTGGAGTACA AGTCCTTGCA GTGGTTCGGG GCAACAGTTC GAGCCCATGG 781 CTCCTCCATC TTGGCATGCG CTCCACTGTA CAGCTGGCGC ACANNNAANG ANCCACTGNN 841 NGACCCCGNG GGNCACCNGC TACNTCTNCA CANNTAANTT CACCCNAATT CTGNNNTATG 901 CACCCNGCNG CNCANNNTTC ANCNNGNNNN CNNNACAGGN NNNNNGNCNA NNNNNGNNNN 961 NNNNNN // |
Primer: bGH-M_R (Pr0747) Region: bGHp(A),attB2,PI-SceI,insert3' Sequence file: RDB07658_A9Kbb.seq ![]() |
>07658_07658_A9Kb_2_bGH-M_R_C11_08_ABI24.ab1 1 NNNNNNNNNN NNNNNNNGNN GGGCNNNCAA CAGNTGGCTG GCAACTAGAA GGCACAGTCG 61 AGGCTGATCA GCGGGTTTAA ACGGGCCCTC TAGACTCGAG CGGCCGCCAC TGTGCTGGAT 121 GGGTACTGCA GCCGATTCAT TAATGCAGGT TAACCTGGCT TATCGAAATT AATACGACTC 181 ACTATAGGGA GACCGGCAGA TCTACCACTT TGTACAAGAA AGCTGGGTCA GGAAACAGCT 241 ATGACCATGT GCCATTTCAT TACCTCTTTC TCCGCACCCG ACATAGATGC CTCGAGTTTT 301 TTTTTTTTTT TTTTGGTCAG TGGGGGCACT GGGTCANATN NATTGCACTT GCAACANANT 361 TTAAATAANT CCTGGGTGTC TGGTGCCAAG GTGAGGGAAG GGTTGGGCAN ANANATGAGG 421 GGCAGCATCA NTGCAGCTGG CAGGCANAAC CCAAATTCTG CAGGCCCAGG ACAGTGGGCT 481 CCCCTTTCTC TGGGGAACAG GGAGGGCCTG TGTCTGGCCA GGCTGANGTT CCANATNNGT 541 TGCCATCATG GCCCCTTCNN GGTCCTGGGA AATTCCTGGC TTCTCCTAAA TCANGGTGAA 601 CTGGGCCTCC AGNATCANGT CTGGAGCANG CCCAAATATA GTCCTGGATC TGCCTGGATT 661 ANGTGCCAAT GTCTGANTCT GGGTTCCANA TNNACTCCNG ACNCCAGGCT GGATCTGNNC 721 CCATTTGAGT TCTGATTCCC CTNGGANCTG GGCTCTGGGC CCTGGGCCAG CATCTATCCN 781 TGTGTGGNAT CTGTCCTGAN CTGGTCCTGG GGCANCNTGC ATAGTTAGTG NTCTTTGTTG 841 GCCCNCCAGG GNGGGGNTGT NNNGANCTGN NNNGNNNTNN NNNNNNNAGT TNCNNNNNNN 901 TANNNNGGGG NNNNNTTTGG NTNTC // |
Primer: hITGA5-B_F1 (Pr0777) Region: insert3' Sequence file: RDB07658_A9Kbc.seq ![]() |
>07658_07658_A9Kb_2_hITGA5-B_F1_A05_02_ABI24.ab1 1 NNNNNNNNNN NNNNNNNNNN NAGNNGCTGG CCCNGGGCCC NGNNCCCAGC TCCNAGGGGA 61 ANCAGAACTC AAATGGGGCC AGATCCAGCC TGGGGTCTGG AGTTGATCTG GAACCCAGAC 121 TCAGACATTG GCACCTAATC CAGGCAGATC CAGGACTATA TTTGGGCCTG CTCCAGACCT 181 GATCCTGGAG GCCCAGTTCA CCCTGATTTA GGAGAAGCCA GGAATTTCCC AGGACCCTGA 241 AGGGGCCATG ATGGCAACAG ATCTGGAACC TCAGCCTGGC CAGACACAGG CCCTCCCTGT 301 TCCCCAGAGA AAGGGGAGCC CACTGTCCTG GGCCTGCAGA ATTTGGGTTC TGCCTGCCAG 361 CTGCACTGAT GCTGCCCCTC ATCTCTCTGC CCAACCCTTC CCTCACCTTG GCACCAGACA 421 CCCAGGACTT ATTTAAACTC TGTTGCAAGT GCAATAAATC TGACCCAGTG CCCCCACTGA 481 CCAAAAAAAA AAAAAAAAAN NTCNAGGCAT CTATGTCGGG TGCGGAGAAA GAGGTAATGA 541 AATGGCACAT GGTCATAGCT GTTTCCTGAC CCAGCTTTCT TGTACAAAGT GGTAGATCTG 601 CCGGTCTCCC TATAGTGAGT CGTATTAATT TCGATAAGCC AGGTTAACCT GCATTAATGA 661 ATCGGCTGCA GTACCCATCC AGCACAGTGG CGGCCGCTCG AGTCTANAGG GCCCGTTTAA 721 ACNCGCTGAT CAGCCTCNAC NGTGCCTTCN ANTTGCCAGC CNTCTGTTGT TTGCCCCTCC 781 CCCGNGCCTT CCTTGACCCN NNNANGGNGN CNCTCCCACT NNNCTTTNNN NNNNAAANNA 841 NNAAANTGCN NCNNNNNNNC NNNNTNNNNN NCNNTNNNNN CTGGGGGNNN NGGGNNNNGG 901 GNNN // |
Primer: SV40pro_ori_F (Pr0731) Region: SV40 pro_ori,NeoR Sequence file: RDB07658_A9Kbd.seq ![]() |
>07658_07658_A9Kb_2_SV40pro_ori_F_D11_11_ABI24.ab1 1 NNNNNNNNNN NNNNNNNNNN CTGCCTCTGN NCTATTCNNG AAGTAGTGAG GAGGCTTTTT 61 TGGAGGCCTA NGCTTTTGCA AAAAGCTCCC GGGAGCTTGT ATATCCATTT TCGGATCTGA 121 TCAAGAGACA GGATGAGGAT CGTTTCGCAT GATTGAACAA GATGGATTGC ACGCAGGTTC 181 TCCGGCCGCT TGGGTGGAGA GGCTATTCGG CTATGACTGG GCACAACAGA CAATCGGCTG 241 CTCTGATGCC GCCGTGTTCC GGCTGTCAGC GCAGGGGCGC CCGGTTCTTT TTGTCAAGAC 301 CGACCTGTCC GGTGCCCTGA ATGAACTGCA GGACGAGGCA GCGCGGCTAT CGTGGCTGGC 361 CACGACGGGC GTTCCTTGCG CAGCTGTGCT CGACGTTGTC ACTGAAGCGG GAAGGGACTG 421 GCTGCTATTG GGCGAAGTGC CGGGGCAGGA TCTCCTGTCA TCTCACCTTG CTCCTGCCGA 481 GAAAGTATCC ATCATGGCTG ATGCAATGCG GCGGCTGCAT ACGCTTGATC CGGCTACCTG 541 CCCATTCGAC CACCAAGCGA AACATCGCAT CGAGCGAGCA CGTACTCGGA TGGAAGCCGG 601 TCTTGTCGAT CAGGATGATC TGGACGAAGA GCATCAGGGG CTCGCGCCAG CCGAACTGTT 661 CGCCAGGCTC AAGGCGCGCA TGCCCGACGG CGANGATCTC GTCGTGACCC ATGGCGATGC 721 CTGCTTGCCG AATATCATGG TGGANNATGG CCGCTTTTCT GGATTCATCG ACTGTGGCCG 781 GCTGGGTGTG GCGGANCGCT ATCAGGACAT AGCGTTGGCT ACCCGNGATA TTGCTGAAGA 841 NCTTGGCGGC GAANGGGCTG NNCGCTTCCT CGNGCTTTAC NGNATCGCCG CNNCNNANNC 901 GCANCGCATC GCCNTCNANN GCNNNNNNNN CNANNNCTTN NNANCGGGNN NNNNGGGNNN 961 NNAANNNNNN NNNN // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
original | Ishii, K., Selective gene transfer into neurons via Na,K-ATPase beta1. Targeting gene transfer with monoclonal antibody and adenovirus vector. J. Gene Med., 10, 597-609 (2008). PMID 18383483. |
---|---|
original | Tanaka, T., arcinoembryonic antigen-targeted selective gene therapy for gastric cancer through FZ33 fiber-modified adenovirus vectors. Clin. Cancer Res., 12, 3803-3813 (2006). PMID 16778108. |
Featured content